{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T08:46:54Z","timestamp":1767343614895,"version":"3.48.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jvir.2025.08.045","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:26:30Z","timestamp":1757550390000},"page":"107833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tumor-Absorbed Dose, Metabolic Response, and Survival after Yttrium-90 Radioembolization in Patients with Breast Cancer Liver Metastases"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4008-3395","authenticated-orcid":false,"given":"Osman Melih","family":"Topcuo\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-9394","authenticated-orcid":false,"given":"T\u00fcrkay","family":"Toklu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalan Alan","family":"Sel\u00e7uk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9228-3703","authenticated-orcid":false,"given":"Bet\u00fcl","family":"Uzuno\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2025.08.045_bib1","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.045_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00259-022-05956-w","article-title":"Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group","volume":"50","author":"Salem","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2025.08.045_bib3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jvir.2024.07.006","article-title":"Outcomes analysis of yttrium-90 radioembolization for tumors other than metastatic colorectal cancer from the Radiation-Emitting SIR-Spheres in Nonresectable (RESiN) Registry","volume":"35","author":"Zhou","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.045_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2214\/AJR.20.25315","article-title":"Yttrium-90 hepatic radioembolization for advanced chemorefractory metastatic colorectal cancer: survival outcomes based on right- versus left-sided primary tumor location","volume":"217","author":"Wu","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jvir.2025.08.045_bib5","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1200\/JCO.21.01839","article-title":"Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial","volume":"39","author":"Mulcahy","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2025.08.045_bib6","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/cncr.21778","article-title":"Metastatic patterns in adenocarcinoma","volume":"106","author":"Hess","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2025.08.045_bib7","article-title":"Breast cancer liver metastasis: pathogenesis and clinical implications","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jvir.2025.08.045_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4251\/wjgo.v12.i2.228","article-title":"Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: a systematic review","volume":"12","author":"Feretis","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2025.08.045_bib9","article-title":"Transarterial yttrium-90 glass microsphere radioembolization of chemotherapy-refractory breast cancer liver metastases: results of a single institution retrospective study","volume":"7","author":"Barakat","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.jvir.2025.08.045_bib10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jvir.2008.01.009","article-title":"Radioembolization in patients with hepatic metastases from breast cancer","volume":"19","author":"Jakobs","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.045_bib11","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00270-022-03254-4","article-title":"Study protocol: efficacy and safety of radioembolization (REM) as an early modality (EM) therapy for metastatic breast cancer (BR) to the liver with Y90 (REMEMBR Y90)","volume":"45","author":"Wu","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2025.08.045_bib12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jvir.2023.03.011","article-title":"Evolution of personalized dosimetry for radioembolization of hepatocellular carcinoma","volume":"34","author":"Knight","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.045_bib13","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2967\/jnumed.120.255745","article-title":"Dose-response and dose-toxicity relationships for glass 90Y radioembolization in patients with liver metastases from colorectal cancer","volume":"62","author":"Alsultan","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jvir.2025.08.045_bib14","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"49","author":"Weber","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2025.08.045_bib15","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1007\/s00259-022-05774-0","article-title":"A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with yttrium-90: the TARGET study","volume":"49","author":"Lam","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2025.08.045_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40658-022-00520-9","article-title":"Maximum tumor-absorbed dose measured by voxel-based multicompartmental dosimetry as a response predictor in yttrium-90 radiation segmentectomy for hepatocellular carcinoma","volume":"10","author":"Orcajo Rinc\u00f3n","year":"2023","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.jvir.2025.08.045_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1148\/radiol.2020191606","article-title":"Relationship of tumor radiation-absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH study","volume":"296","author":"Hermann","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2025.08.045_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109539","article-title":"Relationship of radiation dose to efficacy of radioembolization of liver metastasis from breast cancer","volume":"136","author":"Ridouani","year":"2021","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jvir.2025.08.045_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jvir.2019.12.013","article-title":"Predictors of survival after yttrium-90 radioembolization of chemotherapy-refractory hepatic metastases from breast cancer","volume":"31","author":"Davisson","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.08.045_bib20","article-title":"Selective internal radiation therapy of metastatic breast cancer to the liver: a meta-analysis","volume":"12","author":"Liu","year":"2022","journal-title":"Front Oncol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325005937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325005937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T08:41:19Z","timestamp":1767343279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044325005937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1051044325005937"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2025.08.045","relation":{},"ISSN":["1051-0443"],"issn-type":[{"type":"print","value":"1051-0443"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-Absorbed Dose, Metabolic Response, and Survival after Yttrium-90 Radioembolization in Patients with Breast Cancer Liver Metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2025.08.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2025","name":"copyright","label":"Copyright"}],"article-number":"107833"}}